FSC PASS Issues Advisory on Mycoplasma Genitalium STI
FSC PASS has issued an advisory on Mycoplasma genitalium ("M. Gen"), a STI FSC PASS said is "rarely tested for in the US but may be increasing in prevalence." FSC PASS said it does not consider M. Gen to be "a serious threat to the performer pool" at this time.
Posted On 12 Mar 2019
















